China SXT Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $6.4M | $17.5M | $9.3M |
| FY2020 | $12.3M | $21.7M | $7.3M |
| FY2021 | $18.6M | $34.5M | $13.4M |
| FY2022 | $17.1M | $33.5M | $15.6M |
| FY2023 | $14.9M | $29.6M | $17.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $6.4M | $17.5M | $9.3M |
| FY2020 | $12.3M | $21.7M | $7.3M |
| FY2021 | $18.6M | $34.5M | $13.4M |
| FY2022 | $17.1M | $33.5M | $15.6M |
| FY2023 | $14.9M | $29.6M | $17.4M |